1. Receptor activator of nuclear factor κB expression is a prognostic factor in human osteosarcoma
   KLEMENS TRIEB et al, 2015, Oncology Letters CrossRef
2. Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration
   Zhihao Chen et al, 2022, Cancer Cell International CrossRef
3. Timing of treatment in osteosarcoma: challenges and perspectives – a scoping review
   Michael S. Kim et al, 2022, BMC Cancer CrossRef
4. Insight into the interplay between mitochondria-regulated cell death and energetic metabolism in osteosarcoma
   Hong Toan Lai et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
5. Review of microRNA in osteosarcoma and chondrosarcoma
   Le Chang et al, 2015, Medical Oncology CrossRef
6. Characterization of the Secretome of a Specific Cell Expressing Mutant Methionyl-tRNA Synthetase in Co-Culture Using Click Chemistry
   Sungho Shin et al, 2022, International Journal of Molecular Sciences CrossRef
7. Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions
   Harpreet Kaur et al, 2022, Head and Neck Pathology CrossRef
8. ABT-737 potentiates cisplatin-induced apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway
   Fengtian Zhang et al, 2017, Oncology Reports CrossRef